Results 101 to 110 of about 8,106 (209)

Safety and Efficacy of Ticlopidine After Stent Placement [PDF]

, 2000
Patrick Henry, Fabrice Béverelli
openalex   +1 more source

NEW PROPRIETARY BRANDS: Ticlopidine hydrochloride [PDF]

, 2000

openalex   +1 more source

Novel Situations of Endothelial Injury in Stroke — Mechanisms of Stroke and Strategy of Drug Development: Protective Effects of Antiplatelet Agents Against Stroke

Journal of Pharmacological Sciences, 2011
.: Stroke is the second cause of mortality worldwide, and intravenous administration of tissue plasminogen activator (t-PA) within 3 h of symptom onset is the only treatment proven effective for re-establishment of cerebral blood flow following acute ...
Masamitsu Shimazawa, Hideaki Hara
doaj  

Changes in Coagulation and Fibrinolysis and Effects of Ticlopidine and Cisternal Drainage in the Acute Phase Following Aneurysm Rupture

, 1990
Osamu Toyoda, Hideo Nakajima, Hideaki NUKUI   +2 more
openalex   +2 more sources

Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events [PDF]

, 2001
Steven R. Steinhubl, Stephen G. Ellis, Kathy Wolski, A. Michael Lincoff, Eric J. Topol   +4 more
openalex   +1 more source

Efficacy and safety of antiplatelet therapy for secondary prevention of small subcortical infarction: A systematic review and network meta-analysis. [PDF]

Eur Stroke J
Feng X, Du J, Qu T, Xu S, Zhu W.
europepmc   +1 more source

PLATELET ACTIVITY IN PATIENTS TREATED WITH TICLOPIDINE OR SODIUM OZAGREL

, 1993
H Wada
openalex   +2 more sources

Sex differences in CYP450-based sodium dehydroacetate metabolism and its metabolites in rats. [PDF]

NPJ Sci Food
Zhang M, Du P, Xiao Y, Liu H, Wang M, Zhang Y, Chen X.   +6 more
europepmc   +1 more source

Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: Results from the swedish ticlopidine multicentre study (STIMS)

, 1995
David Bergqvist, B Almgren, J. P. Dickinson   +2 more
openalex   +1 more source

SARS-CoV-2 Vaccination Can Only Be Held Responsible for Thrombotic Thrombocytopenic Purpura After All Differentials Have Been Ruled Out. [PDF]

HCA Healthc J Med
Finsterer J.
europepmc   +1 more source